ホームページへ
4.6/5
TrustPilot
820К+ 2014年以降患者がサポートを受けています
50
1,500 クリニック
6K+ レビュー
3K+ 3,000名以上の資格を持つ医師

タイでの神経芽細胞腫の複雑治療費用について今すぐご確認ください

タイでの神経芽細胞腫の複雑治療の平均価格は$55,000 / 1,870,000฿、最低価格は$45,000 / 1,530,000฿、最高価格は$65,000 / 2,210,000฿です
タイトルコオーストリア
神経芽細胞腫の複雑治療から $45,000 / 1,530,000฿から $28,000 / 952,000฿から $180,000 / 6,120,000฿
データは2026年April月時点でBookimedにより検証され、世界21件のクリニックからの患者リクエストと公式見積もりに基づいています。中央値費用は実際の請求書(2024年-2026年)に基づいており毎月更新されます。実際の価格は異なる場合があります。

Bookimedでのお客様のメリットと保証

直接価格

Bookimedは神経芽細胞腫の複雑治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで神経芽細胞腫の複雑治療代を直接お支払いいただきます。

検証済みクリニック・医師のみ

Bookimedはお客様の安全に取り組んでいます。神経芽細胞腫の複雑治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。

無料24時間365日サポート

Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。神経芽細胞腫の複雑治療の旅路でお一人になることはありません。

なぜ当社を?

Bookimed専属アシスタント

  • すべての段階でサポート
  • 適切なクリニックと医師の選択をサポート
  • 迅速で便利な情報アクセスを確保

タイでの神経芽細胞腫の複雑治療概要

要点
関連手術・費用
仕組みについて
メリット
お支払い
患者様が推奨 -
85%
手術時間 - 4 時間
滞在国での滞在 - 30 日
リハビリテーション - 60 日
麻酔 - 全身麻酔
処理済みリクエスト - 1390
Bookimed手数料 - $0

タイで神経芽細胞腫の複雑治療の医学評価を受ける:その分野の最高の専門医をお選びください

すべての医師を見る

Bookimed患者のビデオストーリー

Amanda
My companion and I were treated with such kindness — I have nothing but admiration for the entire team.
治療: 乳房切除術
Randolph
Stay strong, stay informed, and never underestimate the power of cutting-edge treatments and a solid support system.
治療: 肝動脈内放射線療法

このコンテンツを共有

更新済み: 05/27/2022
著者
アンナ・レオノヴァ
アンナ・レオノヴァ
コンテンツマーケティングチーム責任者
10年以上の経験を持つ認定医療ライターで、文学修士号を持ち、世界中の医療専門家のインタビューに基づくBookimedの信頼できるコンテンツを開発しています。
Fahad Mawlood
医学編集者・データサイエンティスト
一般開業医。4つの科学賞受賞。西アジアでの勤務経験。アラビア語を話す患者様をサポートする医療チームの元チームリーダー。現在はデータ処理と医療コンテンツの正確性を担当
Fahad Mawlood Linkedin
このページは、さまざまな国で利用可能な各種医療状態、治療、ヘルスケアサービスに関する情報を掲載する場合があります。コンテンツは情報提供のみを目的として提供されており、医療アドバイスやガイダンスとして解釈されるべきではないことをご承知おきください。医療治療を開始または変更する前に、医師または資格のある医療専門家にご相談ください。

タイでの神経芽細胞腫の複雑治療に関するFAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

What are the qualifications and experience of Thai oncologists specializing in neuroblastoma treatment?

Thai oncologists treating neuroblastoma are pediatric hematologist-oncologists with six-year medical degrees and three-year pediatric residencies. Most hold Thai Board of Pediatrics diplomas. They must complete a two-year sub-specialty fellowship in Pediatric Hematology and Oncology to manage complex childhood solid tumors.

  • Medical education: Doctors complete six years at Medical Council of Thailand recognized schools.
  • Specialization: Surgeons like those at Bumrungrad International Hospital lead multidisciplinary oncology teams.
  • International training: Leading specialists often hold American Board of Pediatrics certifications from US institutions.
  • Research output: Senior experts frequently publish 30-45 papers in international pediatric oncology journals.

Bookimed Expert Insight: Thai specialists often balance general pediatric oncology with radiology. Dr. Nichakorn Seehirunwong at Intrarat Hospital holds certifications in both oncology and diagnostic radiology. This dual expertise helps in precisely interpreting neuroblastoma imaging for staging. Patients should prioritize doctors with this specific diagnostic background.

Patient Consensus: Families emphasize that while Thai specialists are highly competent in chemotherapy, local case volumes are low. Many recommend verifying if the oncologist follows current Children's Oncology Group international risk protocols.

How exactly is high-risk neuroblastoma treated in Thailand?

High-risk neuroblastoma treatment in Thailand follows a multi-phase protocol including induction chemotherapy, surgical debulking, and consolidation with stem cell transplantation. Centers like Bumrungrad International Hospital utilize intensity-modulated protocols, often incorporating MIBG therapy and isotretinoin maintenance to target minimal residual disease effectively.

  • Induction phase: Topotecan-based chemotherapy cycles reduce tumor size over 6 months.
  • Surgical intervention: Surgeons perform primary tumor debulking typically after the 4th induction cycle.
  • Consolidation phase: High-dose chemotherapy precedes autologous stem cell transplantation to rescue marrow.
  • Maintenance therapy: Protocols use oral isotretinoin for 6 to 12 months post-transplant.

Bookimed Expert Insight: While national protocols often exclude immunotherapy due to cost, private centers like Bumrungrad International Hospital offer access to dinutuximab. International patients should prioritize these JCI-accredited facilities to ensure their treatment plan aligns with COG-equivalent standards used in the US.

Patient Consensus: Families emphasize that while intensive treatment lasts over 9 months, response tracking via MIBG scans every 3 cycles provides critical updates on progress.

What safety protocols and accreditations ensure quality care?

Quality care for neuroblastoma in Thailand is ensured by Joint Commission International (JCI) accreditation and Global Healthcare Accreditation (GHA) for international patients. Facilities like Bumrungrad International Hospital utilize advanced technologies including robotic surgery, AI-driven diagnostics, and electronic health records to maintain high safety standards and clinical precision.

  • International accreditation: JCI standards ensure rigorous benchmarks for patient safety and infection control protocols.
  • Specialized technology: Top centers integrate AI and digital imaging for precise neuroblastoma tumor staging.
  • Clinical quality: Tracking ISO International Standards and Newsweek-recognized performance indicators ensures reliable medical outcomes.
  • Specialized expertise: Pediatric oncologists like Dr. Nichakorn Seehirunwong provide essential imaging-guided radiation and diagnostic accuracy.

Bookimed Expert Insight: While JCI accreditation is widely promoted, the true safety differentiator for complex pediatric cancers is Global Healthcare Accreditation (GHA). Bumrungrad International Hospital holds this specific certification, which evaluates the entire journey for international families, including unique safety needs during long-term oncology stays.

Patient Consensus: While hospital reputation is a starting point, experienced families emphasize that verifying a surgeon's specific experience with rare pediatric subspecialties is the most critical safety step. Many recommend hiring an independent translator to ensure no critical medical details are lost during complex treatment consultations.

What is the typical recovery timeline and expected results?

Neuroblastoma recovery in Thailand involves a 2 to 6 week initial surgical healing period. High-risk treatments like stem cell transplants or high-dose chemotherapy extend inpatient stays to 1 to 3 months. Most patients return to full activity after 18 months of ongoing therapy and monitoring.

  • Hospitalization stay: Patients typically remain inpatient for 4 to 8 weeks following major surgery.
  • Intensive phase: High-risk cases often require up to 4 months of total hospital stay.
  • Full recovery: Children usually return to school full-time roughly 18 months after finishing MIBG therapy.
  • Long-term results: Low-risk cases often achieve cancer-free status within 6 months with minimal side effects.

Bookimed Expert Insight: Thai facilities like Bumrungrad International Hospital combine JCI-accredited safety with aggressive clinical protocols. This approach often results in surgical recovery times of 2 to 4 weeks. This is notably faster than the 6-week recovery standard seen in many Western oncology centers.

Patient Consensus: Families often report that post-treatment fatigue and neuropathy persist for 1 to 2 years. While high-risk cases carry relapse concerns, many achieve a functional cure where residual disease is successfully managed long-term.

Who is a suitable candidate for neuroblastoma therapy in Thailand?

Suitable candidates for neuroblastoma therapy in Thailand include pediatric patients categorized by the Thai Pediatric Oncology Group (ThaiPOG) as low, intermediate, or high-risk. High-risk eligibility requires children over 18 months with stage 4 metastatic disease or any patient with confirmed MYCN gene amplification.

  • Risk classification: ThaiPOG protocols categorize patients by age, disease stage, and tumor biology.
  • Diagnostic criteria: Candidates must provide MYCN amplification testing and International Neuroblastoma Risk Group (INRG) staging.
  • Health stability: International patients must be stable enough for 4–6 week stays in Bangkok.
  • Specialized eligibility: MIBG therapy requires tumors that take up tracers and adequate organ function.

Bookimed Expert Insight: While public systems have limitations, private centers like Bumrungrad International Hospital serve over 50% international patients. This high volume allows clinics to offer MIBG therapy and complex resections without the long waitlists typical in the US. Parents should ensure pre-treatment scans show less than 50% bone metastases for the best outcomes.

Patient Consensus: Families emphasize that it is best for children with stage 1–3 disease who have stable vitals. Most recommend arranging tele-oncology follow-up care before returning home to ensure long-term recovery success.

What accommodations and support services are available for international families?

International families in Thailand receive comprehensive support through JCI-accredited hospitals like Bumrungrad International Hospital, featuring English translation, HALAL or Kosher dining, and airport pickups. While clinics assist with medical visa paperwork for 30-90 day extensions, families typically arrange private housing in nearby serviced apartments.

  • Medical visas: Hospitals provide essential documentation for 30-90 day medical stay extensions.
  • Language support: Dedicated English translators facilitate communication during all clinical consultations and procedures.
  • Arrival logistics: Complimentary airport pickup services are standard for international patients at major centers.
  • Dietary options: In-hospital dining includes certified HALAL and Kosher meals for diverse families.

Bookimed Expert Insight: Thai hospitals excel at clinical hospitality but rarely provide long-term family housing. Data shows 50% of Bumrungrad patients are international, driving a massive market for serviced apartments in the Sukhumvit area. Booking these privately often saves families 40% compared to hospital-managed guest wings while maintaining proximity to care.

Patient Consensus: Families recommend joining local expat groups for emotional support since formal international lounges are rare. Most emphasize proactive self-advocacy to secure child psychological services alongside standard medical treatments.

Which Thai hospitals are most recognized for complex neuroblastoma care?

Thailand center for neuroblastoma care features Joint Commission International accredited hospitals in Bangkok specializing in high-risk pediatric oncology. Facilities like Bumrungrad International and Samitivej Children’s Hospital provide advanced interventions including haploidentical bone marrow transplants, molecular diagnostics, and immunotherapy protocols for complex stage 3 and 4 cases.

  • Bumrungrad International: Features the Horizon Cancer Center with multidisciplinary tumor boards and targeted inhibitors.
  • Samitivej Children’s Hospital: Utilizes advanced stem cell transplantation technology for high-risk pediatric malignancies.
  • Wattanosoth Cancer Hospital: Provides specialized pediatric neurosurgery and stereotactic radiotherapy for solid tumors.
  • Vejthani Hospital: Recognized for quaternary care with specific expertise in complex bone marrow transplants.

Bookimed Expert Insight: Bumrungrad International Hospital manages over 1 million patients annually with 50% arriving from 190 countries. This massive international volume allows their 1,300 doctors to maintain proficiency in rare conditions like neuroblastoma. When selecting a facility, prioritize those with dedicated pediatric oncology departments rather than general cancer centers.

Patient Consensus: Families emphasize the importance of requesting specific case volume data for high-risk neuroblastoma. Many recommend confirming if a facility performs MYCN amplification testing before starting treatment.

無料相談を受ける

最適な連絡方法をお選びください